Caffeic Acid NEW
| Price | $29 |
| Package | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-10-31 |
Product Details
| Product Name: Caffeic Acid | CAS No.: 331-39-5 |
| Purity: 98.96% | Supply Ability: 10g |
| Release date: 2025/10/31 |
Product Introduction
Bioactivity
| Name | Caffeic Acid |
| Description | Caffeic acid is a dual inhibitor of 5-lipoxygenase and TRPV1 ion channels. |
| In vitro | METHODS: Human A549 cells were treated with Caffeic Acid for 48 h, and cell growth inhibition was measured using MTT assay. RESULTS: Caffeic Acid inhibited the growth of A549 cells (IC50=0.7 mM). [1] METHODS: Human AGS and HCT-116 cells were treated with Caffeic Acid for 96 hours, and cell growth inhibition was detected using MTT assay. RESULTS: Caffeic Acid inhibited the growth of AGS (IC50=129 μM) and HCT-116 (IC50=29.73 μM) cells. [2] |
| In vivo | METHODS: To study the anti-pruritus effect of Caffeic Acid, Caffeic Acid (500 mg/kg) was orally administered to mice induced by histamine and chloroquine. RESULTS: Caffeic acid pretreated mice showed significantly less histamine-induced scratching and chloroquine-induced scratching. [3] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 250 mg/mL (1387.66 mM), Sonication is recommended. |
| Keywords | TRPVChannel | TRPV Channel | TRPChannel | TRP Channel | Transient receptor potential channels | LOX | Lipoxygenase | Inhibitor | inhibit | hTRPA1 | EndogenousMetabolite | Endogenous Metabolite | Caffeic Acid | 5-Lipoxygenase |
| Inhibitors Related | Sucrose | Aceglutamide | Cysteamine hydrochloride | Daidzein | Guanidine hydrochloride | Fumaric acid | Ferulic Acid | Formamide | Glycerol | Thymidine | Naringin | 3-Indoleacetic acid |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Tobacco Monomer Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/25kg |
VIP4Y
|
Nanjing Shunxiang Pharmaceutical Technology Co.,Ltd.
|
2025-09-28 | |
| $0.00/1kg |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-27 | |
| $10.00/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-29 | |
| $0.00/1kg |
VIP2Y
|
Watson Biotechnology Co.,Ltd
|
2024-10-10 | |
| $5.00/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
| $6.00/1kg |
HebeiShuoshengImportandExportco.,Ltd
|
2024-08-07 | ||
| $0.00/1kg |
VIP2Y
|
JINING XINHE CHEMICAL CO., LTD
|
2024-07-20 | |
| $30.00/1kg |
hebei hongtan Biotechnology Co., Ltd
|
2024-05-14 | ||
| $6.00/1kg |
Hebei Longbang Technology Co., Ltd
|
2024-05-08 | ||
| $200.00/1kg |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-04-23 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY

United States